Evidence map›Paper›PMID 41908686›Full record

ArticleEpilepsy & behavior reports2026

Super refractory status epilepticus as an atypical presentation of Hashimoto's encephalopathy.

Andres Chaponan-Lavalle, Jorge Alave, Fred Fernandez, Luciana Chacon Hermoza, Danny M Barrientos-Iman, Roberto Chulluncuy-Rivas, Nelson Diaz

Abstract readCase Reports
In one paragraph

Article in Epilepsy & behavior reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Andres Chaponan-LavalleUniversidad Peruana de Ciencias Aplicadas, Lima, Peru.
Jorge AlaveUniversidad Peruana Union, Lima, Peru.
Fred FernandezClinica Good Hope, Lima, Peru.
Luciana Chacon HermozaUniversidad Peruana de Ciencias Aplicadas, Lima, Peru.
Danny M Barrientos-ImanInstituto Nacional de Ciencias Neurologicas, Lima, Peru.
Roberto Chulluncuy-RivasDepartment of Neurology and Neurological Sciences, Stanford University, Palo Alto, CA, United States.
Nelson DiazUniversidad Peruana Union, Lima, Peru.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hashimoto's encephalopathy (HE), also known as steroid responsive encephalopathy associated with autoimmune thyroiditis (SREAT), is a rare autoimmune disorder characterized by neuropsychiatric manifestations and a favorable response to corticosteroids. Seizures occur in nearly half of patients; however, super refractory status epilepticus (SRSE) is an uncommon initial presentation. We describe a young adult woman with Hashimoto's thyroiditis who developed SRSE after a brief prodrome of headache, confusion, and paranoia. Extensive infectious, metabolic, and autoimmune workup was negative, but anti-thyroid peroxidase and anti-thyroglobulin antibodies were markedly elevated. Brain MRI showed nonspecific subcortical T2/FLAIR hyperintensities. The patient was diagnosed with HE and treated with high dose intravenous methylprednisolone followed by intravenous immunoglobulin, resulting in full neurological recovery and sustained seizure freedom at three-month follow up. This case illustrates the importance of considering HE in patients with unexplained SRSE, as prompt recognition and immunotherapy can be lifesaving.

Indexed as

AutoimmunethyroiditisHashimoto’sencephalopathyImmunotherapyResponsiveencephalopathySuperrefractorystatusepilepticus

Identifiers

PMID41908686
PMCPMC13020096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.